On September 7, 2009
Facet Sneers at Biogen Idec’s Low-Ball Offer…But Investors Might Not
Biogen Idec aired a bit of dirty laundry late Friday, going public with the details of its ongoing attempt to acquire Facet Biotech. Whether you think the offer is fair or a low-ball depends on whether you think biotechs are worth their cash or market value.
0 Comments